Dr. Goy leads the John Theurer Cancer Center, New Jersey’s largest cancer care program. A specialist in lymphoma care, he also directs the state's largest lymphoma treatment and research program. Widely known for his work in mantle cell lymphoma, he was the lead investigator in the development of three FDA-approved drugs for this disease: bortezomib, lenalidomide, and ibrutinib. He is now assessing biomarkers for lymphoma as well as novel anticancer agents, drug combinations, and non-chemotherapy options
Hackensack - John Theurer Cancer Center : 30 Prospect Ave, Hackensack, NJ 07601, USA
Subscribe to the weekly "HealthTree Community for CLL Newsletter" for CLL news, life with CLL stories, CLL clinical trials, CLL 101 articles and events with CLL experts.
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2022 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811
